The patient purchased the clickfine needle from the hospital.When the patient completed an insulin injection at home, the patient observed red spots, bleeding, on the injection site.This prompted the patient to stop using the needle.Several testing and documents were reviewed: bioburden report, endotoxin report, irradiation certificate, biocompatibiilty testing, manufacturing documentations.However, no abnormalities were found.The review of manufacturing history showed no abnormalities or deviations from the validated manufacturing process including the 100% in-process control for needle tip to cannula check prior to fitting of the protective cap.
|
The patient purchased the clickfine needle from the hospital.When the patient completed an insulin injection at home, the patient observed red spots, bleeding, on the injection site.This prompted the patient to stop using the needle.
|